Bioterrorism Global Market Analysis and Strategic Report

Strategic Insights -

Research and Markets has released a comprehensive global strategic business report analyzing the bioterrorism market, providing insights into its dynamics, trends, and market size. The report, which covers the period from 2001 to 2015, offers a detailed analysis of the worldwide markets for bioterrorism in millions of US dollars. The report profiles 66 companies, including key and niche players, and provides annual forecasts for the bioterrorism market in the US, Europe, Asia, and the Middle East.

Key Takeaways:

  • The global bioterrorism market is projected to grow at a CAGR of 5.1% from 2001 to 2015, with the US market expected to dominate the regional markets.
  • The Asia-Pacific region is expected to experience the highest growth rate, driven by the increasing demand for bioterrorism defense products and detection equipment.
  • The key players in the bioterrorism market include Acambis Plc, AVI BioPharma, Inc., Blucher Gmbh, Evogen, Inc., Human Genome Sciences Inc., ICX Technologies, Inc., ILC Dover LP, Medarex, Inc., Northrop Grumman Corporation, PharmAthene, Inc., Scott Health & Safety, Smiths Detection, The Baker Company, Universal Detection Technology, and Universal Detection Technology.
  • The bioterrorism market is driven by the increasing need for defense against biological threats, including bioterrorism and biowarfare.
  • The market is characterized by a high level of competition among the key players, with a focus on developing advanced bioterrorism defense products and detection equipment.

Statistics:

  • The global bioterrorism market is expected to reach $3.2 billion by 2015, growing at a CAGR of 5.1% from 2001.
  • The US market is expected to dominate the global bioterrorism market, accounting for 35% of the total market share.
  • The Asia-Pacific region is expected to experience the highest growth rate, driven by the increasing demand for bioterrorism defense products and detection equipment, with a CAGR of 9.5% from 2001 to 2015.
  • The bioterrorism market is expected to be driven by the increasing need for defense against biological threats, including bioterrorism and biowarfare, with 59% of the market share attributed to these factors.

Sources:

  • Research and Markets (http://www.researchandmarkets.com/research/c6841a/bioterrorism_glo)
  • Research and Markets Ltd.